Global Erythropoietin Drug Market Research Report 2023

Report ID: 1983673 | Published Date: Jan 2025 | No. of Page: 82 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Erythropoietin Drug Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Epoetin-alfa
        1.2.3 Darbepoetin-alfa
        1.2.4 Epoetin-beta
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Erythropoietin Drug Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Anemia
        1.3.3 Kidney Disorders
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Erythropoietin Drug Market Perspective (2017-2028)
    2.2 Erythropoietin Drug Growth Trends by Region
        2.2.1 Erythropoietin Drug Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Erythropoietin Drug Historic Market Size by Region (2017-2022)
        2.2.3 Erythropoietin Drug Forecasted Market Size by Region (2023-2028)
    2.3 Erythropoietin Drug Market Dynamics
        2.3.1 Erythropoietin Drug Industry Trends
        2.3.2 Erythropoietin Drug Market Drivers
        2.3.3 Erythropoietin Drug Market Challenges
        2.3.4 Erythropoietin Drug Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Erythropoietin Drug Players by Revenue
        3.1.1 Global Top Erythropoietin Drug Players by Revenue (2017-2022)
        3.1.2 Global Erythropoietin Drug Revenue Market Share by Players (2017-2022)
    3.2 Global Erythropoietin Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Erythropoietin Drug Revenue
    3.4 Global Erythropoietin Drug Market Concentration Ratio
        3.4.1 Global Erythropoietin Drug Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Erythropoietin Drug Revenue in 2021
    3.5 Erythropoietin Drug Key Players Head office and Area Served
    3.6 Key Players Erythropoietin Drug Product Solution and Service
    3.7 Date of Enter into Erythropoietin Drug Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Erythropoietin Drug Breakdown Data by Type
    4.1 Global Erythropoietin Drug Historic Market Size by Type (2017-2022)
    4.2 Global Erythropoietin Drug Forecasted Market Size by Type (2023-2028)
5 Erythropoietin Drug Breakdown Data by Application
    5.1 Global Erythropoietin Drug Historic Market Size by Application (2017-2022)
    5.2 Global Erythropoietin Drug Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Erythropoietin Drug Market Size (2017-2028)
    6.2 North America Erythropoietin Drug Market Size by Country (2017-2022)
    6.3 North America Erythropoietin Drug Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Erythropoietin Drug Market Size (2017-2028)
    7.2 Europe Erythropoietin Drug Market Size by Country (2017-2022)
    7.3 Europe Erythropoietin Drug Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Erythropoietin Drug Market Size (2017-2028)
    8.2 Asia-Pacific Erythropoietin Drug Market Size by Country (2017-2022)
    8.3 Asia-Pacific Erythropoietin Drug Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Erythropoietin Drug Market Size (2017-2028)
    9.2 Latin America Erythropoietin Drug Market Size by Country (2017-2022)
    9.3 Latin America Erythropoietin Drug Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Erythropoietin Drug Market Size (2017-2028)
    10.2 Middle East & Africa Erythropoietin Drug Market Size by Country (2017-2022)
    10.3 Middle East & Africa Erythropoietin Drug Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Amgen
        11.1.1 Amgen Company Detail
        11.1.2 Amgen Business Overview
        11.1.3 Amgen Erythropoietin Drug Introduction
        11.1.4 Amgen Revenue in Erythropoietin Drug Business (2017-2022)
        11.1.5 Amgen Recent Development
    11.2 Johnson & Johnson
        11.2.1 Johnson & Johnson Company Detail
        11.2.2 Johnson & Johnson Business Overview
        11.2.3 Johnson & Johnson Erythropoietin Drug Introduction
        11.2.4 Johnson & Johnson Revenue in Erythropoietin Drug Business (2017-2022)
        11.2.5 Johnson & Johnson Recent Development
    11.3 Roche
        11.3.1 Roche Company Detail
        11.3.2 Roche Business Overview
        11.3.3 Roche Erythropoietin Drug Introduction
        11.3.4 Roche Revenue in Erythropoietin Drug Business (2017-2022)
        11.3.5 Roche Recent Development
    11.4 Galenica
        11.4.1 Galenica Company Detail
        11.4.2 Galenica Business Overview
        11.4.3 Galenica Erythropoietin Drug Introduction
        11.4.4 Galenica Revenue in Erythropoietin Drug Business (2017-2022)
        11.4.5 Galenica Recent Development
    11.5 Emcure
        11.5.1 Emcure Company Detail
        11.5.2 Emcure Business Overview
        11.5.3 Emcure Erythropoietin Drug Introduction
        11.5.4 Emcure Revenue in Erythropoietin Drug Business (2017-2022)
        11.5.5 Emcure Recent Development
    11.6 Kyowa Hakko Kirin
        11.6.1 Kyowa Hakko Kirin Company Detail
        11.6.2 Kyowa Hakko Kirin Business Overview
        11.6.3 Kyowa Hakko Kirin Erythropoietin Drug Introduction
        11.6.4 Kyowa Hakko Kirin Revenue in Erythropoietin Drug Business (2017-2022)
        11.6.5 Kyowa Hakko Kirin Recent Development
    11.7 3SBio
        11.7.1 3SBio Company Detail
        11.7.2 3SBio Business Overview
        11.7.3 3SBio Erythropoietin Drug Introduction
        11.7.4 3SBio Revenue in Erythropoietin Drug Business (2017-2022)
        11.7.5 3SBio Recent Development
    11.8 Biocon
        11.8.1 Biocon Company Detail
        11.8.2 Biocon Business Overview
        11.8.3 Biocon Erythropoietin Drug Introduction
        11.8.4 Biocon Revenue in Erythropoietin Drug Business (2017-2022)
        11.8.5 Biocon Recent Development
    11.9 LG Life Sciences
        11.9.1 LG Life Sciences Company Detail
        11.9.2 LG Life Sciences Business Overview
        11.9.3 LG Life Sciences Erythropoietin Drug Introduction
        11.9.4 LG Life Sciences Revenue in Erythropoietin Drug Business (2017-2022)
        11.9.5 LG Life Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Erythropoietin Drug Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Epoetin-alfa
    Table 3. Key Players of Darbepoetin-alfa
    Table 4. Key Players of Epoetin-beta
    Table 5. Key Players of Others
    Table 6. Global Erythropoietin Drug Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Erythropoietin Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Erythropoietin Drug Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Erythropoietin Drug Market Share by Region (2017-2022)
    Table 10. Global Erythropoietin Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Erythropoietin Drug Market Share by Region (2023-2028)
    Table 12. Erythropoietin Drug Market Trends
    Table 13. Erythropoietin Drug Market Drivers
    Table 14. Erythropoietin Drug Market Challenges
    Table 15. Erythropoietin Drug Market Restraints
    Table 16. Global Erythropoietin Drug Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Erythropoietin Drug Market Share by Players (2017-2022)
    Table 18. Global Top Erythropoietin Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Erythropoietin Drug as of 2021)
    Table 19. Ranking of Global Top Erythropoietin Drug Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Erythropoietin Drug Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Erythropoietin Drug Product Solution and Service
    Table 23. Date of Enter into Erythropoietin Drug Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Erythropoietin Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Erythropoietin Drug Revenue Market Share by Type (2017-2022)
    Table 27. Global Erythropoietin Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Erythropoietin Drug Revenue Market Share by Type (2023-2028)
    Table 29. Global Erythropoietin Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Erythropoietin Drug Revenue Market Share by Application (2017-2022)
    Table 31. Global Erythropoietin Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Erythropoietin Drug Revenue Market Share by Application (2023-2028)
    Table 33. North America Erythropoietin Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Erythropoietin Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Erythropoietin Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Erythropoietin Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Erythropoietin Drug Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Erythropoietin Drug Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Erythropoietin Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Erythropoietin Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Erythropoietin Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Erythropoietin Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Amgen Company Detail
    Table 44. Amgen Business Overview
    Table 45. Amgen Erythropoietin Drug Product
    Table 46. Amgen Revenue in Erythropoietin Drug Business (2017-2022) & (US$ Million)
    Table 47. Amgen Recent Development
    Table 48. Johnson & Johnson Company Detail
    Table 49. Johnson & Johnson Business Overview
    Table 50. Johnson & Johnson Erythropoietin Drug Product
    Table 51. Johnson & Johnson Revenue in Erythropoietin Drug Business (2017-2022) & (US$ Million)
    Table 52. Johnson & Johnson Recent Development
    Table 53. Roche Company Detail
    Table 54. Roche Business Overview
    Table 55. Roche Erythropoietin Drug Product
    Table 56. Roche Revenue in Erythropoietin Drug Business (2017-2022) & (US$ Million)
    Table 57. Roche Recent Development
    Table 58. Galenica Company Detail
    Table 59. Galenica Business Overview
    Table 60. Galenica Erythropoietin Drug Product
    Table 61. Galenica Revenue in Erythropoietin Drug Business (2017-2022) & (US$ Million)
    Table 62. Galenica Recent Development
    Table 63. Emcure Company Detail
    Table 64. Emcure Business Overview
    Table 65. Emcure Erythropoietin Drug Product
    Table 66. Emcure Revenue in Erythropoietin Drug Business (2017-2022) & (US$ Million)
    Table 67. Emcure Recent Development
    Table 68. Kyowa Hakko Kirin Company Detail
    Table 69. Kyowa Hakko Kirin Business Overview
    Table 70. Kyowa Hakko Kirin Erythropoietin Drug Product
    Table 71. Kyowa Hakko Kirin Revenue in Erythropoietin Drug Business (2017-2022) & (US$ Million)
    Table 72. Kyowa Hakko Kirin Recent Development
    Table 73. 3SBio Company Detail
    Table 74. 3SBio Business Overview
    Table 75. 3SBio Erythropoietin Drug Product
    Table 76. 3SBio Revenue in Erythropoietin Drug Business (2017-2022) & (US$ Million)
    Table 77. 3SBio Recent Development
    Table 78. Biocon Company Detail
    Table 79. Biocon Business Overview
    Table 80. Biocon Erythropoietin Drug Product
    Table 81. Biocon Revenue in Erythropoietin Drug Business (2017-2022) & (US$ Million)
    Table 82. Biocon Recent Development
    Table 83. LG Life Sciences Company Detail
    Table 84. LG Life Sciences Business Overview
    Table 85. LG Life Sciences Erythropoietin Drug Product
    Table 86. LG Life Sciences Revenue in Erythropoietin Drug Business (2017-2022) & (US$ Million)
    Table 87. LG Life Sciences Recent Development
    Table 88. Research Programs/Design for This Report
    Table 89. Key Data Information from Secondary Sources
    Table 90. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Erythropoietin Drug Market Share by Type: 2021 VS 2028
    Figure 2. Epoetin-alfa Features
    Figure 3. Darbepoetin-alfa Features
    Figure 4. Epoetin-beta Features
    Figure 5. Others Features
    Figure 6. Global Erythropoietin Drug Market Share by Application in 2021 & 2028
    Figure 7. Anemia Case Studies
    Figure 8. Kidney Disorders Case Studies
    Figure 9. Others Case Studies
    Figure 10. Erythropoietin Drug Report Years Considered
    Figure 11. Global Erythropoietin Drug Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Erythropoietin Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Erythropoietin Drug Market Share by Region: 2021 VS 2028
    Figure 14. Global Erythropoietin Drug Market Share by Players in 2021
    Figure 15. Global Top Erythropoietin Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Erythropoietin Drug as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Erythropoietin Drug Revenue in 2021
    Figure 17. North America Erythropoietin Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Erythropoietin Drug Market Share by Country (2017-2028)
    Figure 19. United States Erythropoietin Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Erythropoietin Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Erythropoietin Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Erythropoietin Drug Market Share by Country (2017-2028)
    Figure 23. Germany Erythropoietin Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Erythropoietin Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Erythropoietin Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Erythropoietin Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Erythropoietin Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Erythropoietin Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Erythropoietin Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Erythropoietin Drug Market Share by Region (2017-2028)
    Figure 31. China Erythropoietin Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Erythropoietin Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Erythropoietin Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Erythropoietin Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Erythropoietin Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Erythropoietin Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Erythropoietin Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Erythropoietin Drug Market Share by Country (2017-2028)
    Figure 39. Mexico Erythropoietin Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Erythropoietin Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Erythropoietin Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Erythropoietin Drug Market Share by Country (2017-2028)
    Figure 43. Turkey Erythropoietin Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Erythropoietin Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Amgen Revenue Growth Rate in Erythropoietin Drug Business (2017-2022)
    Figure 46. Johnson & Johnson Revenue Growth Rate in Erythropoietin Drug Business (2017-2022)
    Figure 47. Roche Revenue Growth Rate in Erythropoietin Drug Business (2017-2022)
    Figure 48. Galenica Revenue Growth Rate in Erythropoietin Drug Business (2017-2022)
    Figure 49. Emcure Revenue Growth Rate in Erythropoietin Drug Business (2017-2022)
    Figure 50. Kyowa Hakko Kirin Revenue Growth Rate in Erythropoietin Drug Business (2017-2022)
    Figure 51. 3SBio Revenue Growth Rate in Erythropoietin Drug Business (2017-2022)
    Figure 52. Biocon Revenue Growth Rate in Erythropoietin Drug Business (2017-2022)
    Figure 53. LG Life Sciences Revenue Growth Rate in Erythropoietin Drug Business (2017-2022)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Amgen
Johnson & Johnson
Roche
Galenica
Emcure
Kyowa Hakko Kirin
3SBio
Biocon
LG Life Sciences
Frequently Asked Questions
Erythropoietin Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Erythropoietin Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Erythropoietin Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Epsom Salt

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More

E-Health Services

E-Health Services market is segmented by players, region (country), by Type and by Application. P ... Read More